FDA Panel Endorses Emergency Use Authorization of Merck's COVID-19 Pill, Molnupiravir

HNGN

01 Dec 2021 0 shares 2 views

FDA Panel Endorses Emergency Use Authorization of Merck's COVID-19 Pill, Molnupiravir

FDA Panel Endorses Emergency Use Authorization of Merck's COVID-19 Pill, Molnupiravir

HNGN

Published 01 Dec 2021

FDA committee recommended Merck's COVID-19 pill molnuparivir to be approved for emergency use for treating mild-to-moderate patients.

You might like

Related news coverage

Merck's COVID-19 pill to arrive in Israel within two weeks

Merck's COVID-19 pill to arrive in Israel within two weeks

Jerusalem Post 23 Dec 2021

Molnupiravir received Emergency Use Authorization on Thursday evening in Israel. It is used to treat mild to moderate coronavirus..

U.S. Adds Merck Pill As 2nd Easy-To-Use Drug Against COVID-19

U.S. Adds Merck Pill As 2nd Easy-To-Use Drug Against COVID-19

Newsy

23 Dec 2021

After Pfizer, US grants emergency use authorization for Merck's COVID-19 pill

DNA

24 Dec 2021

FDA authorizes a 2nd easy-to-use COVID treatment, Merck's antiviral pill
NPR 23 Dec 2021
US adds Merck pill as 2nd easy-to-use drug against COVID-19
SeattlePI.com 23 Dec 2021

Advertisement

More coverage

FDA Panel Backs First-Of-A-Kind COVID-19 Pill From Merck

FDA Panel Backs First-Of-A-Kind COVID-19 Pill From Merck

Watch VideoA panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage..

Newsy 01 Dec 2021